Ornament2.png

Esofin

Esomeprazole Sodium

Short Description

Esofin® containing Esomeprazole sodium (equivalent to Esomeprazole base) as active ingredient is available in 40 mg steril powder for injection.

Indications

Esofin® injection is indicated for : 

  • Gastric antisecretory treatment when the oral route is not possible, such as :  

  • Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux. 

  • Healing of gastric ulcers associated with NSAID therapy. 

  • The short term maintenance of hemostasis and prevention of rebleeding in patients following therapeutic endoscopy for acute bleeding   gastric or duodenal ulcers

Specification

Injection

Esofin® Powder for IV injection 40 mg

  • Each vial contains: Esomeprazole sodium equivalent to Esomeprazole 40 mg.

  • Box, 1 vial @ 40 mg

multi-gyn.png

Gastrointestinal & Hepatobiliary Systems Product